Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mulagha

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Gastroenterology and Hepatology|October 5, 2017
Pathogenesis and treatment of gallstone diseaseHans Fromm, Eneya Mulagha
Current Treatment Options in Gastroenterology|November 30, 2000
Acute CholecystitisMulagha, Fromm
Journal of Gastroenterology and Hepatology|April 14, 2000
Extracorporeal shock wave lithotripsy of gallstones revisited: current status and future promisesE Mulagha, H Fromm
Journal of Health, Population, and Nutrition|April 3, 2024
Modeling time to death for under-five children in Malawi using 2015/16 Demographic and Health Survey: a survival analysisAssa Mulagha-Maganga, Lawrence Kazembe, Martin Ndiragu
Heliyon|November 17, 2022
Profit inefficiency of goat farming in Malawi: A Bayesian approachChifundo Nyakwawa, Assa Mulagha-Maganga, Julius H Mangisoni
Cancer|August 15, 1996
Fadrozole hydrochloride in postmenopausal patients with metastatic breast carcinomaA A Miller, A Lipton, I C Henderson, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1993
The effects of long term fadrozole hydrochloride treatment in patients with advanced stage breast cancerL M Demers, A Lipton, H A Harvey, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1990
The pharmacodynamic inhibition of estrogen synthesis by fadrozole, an aromatase inhibitor, and its pharmacokinetic dispositionG M Kochak, S Mangat, M T Mulagha, et al.
Cancer|June 15, 1996
Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trialsA U Buzdar, R Smith, C Vogel, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1991
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitorR J Santen, L M Demers, J Lynch, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Gastroenterology and Hepatology|October 5, 2017
Pathogenesis and treatment of gallstone diseaseHans Fromm, Eneya Mulagha
Current Treatment Options in Gastroenterology|November 30, 2000
Acute CholecystitisMulagha, Fromm
Journal of Gastroenterology and Hepatology|April 14, 2000
Extracorporeal shock wave lithotripsy of gallstones revisited: current status and future promisesE Mulagha, H Fromm
Journal of Health, Population, and Nutrition|April 3, 2024
Modeling time to death for under-five children in Malawi using 2015/16 Demographic and Health Survey: a survival analysisAssa Mulagha-Maganga, Lawrence Kazembe, Martin Ndiragu
Heliyon|November 17, 2022
Profit inefficiency of goat farming in Malawi: A Bayesian approachChifundo Nyakwawa, Assa Mulagha-Maganga, Julius H Mangisoni
Cancer|August 15, 1996
Fadrozole hydrochloride in postmenopausal patients with metastatic breast carcinomaA A Miller, A Lipton, I C Henderson, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1993
The effects of long term fadrozole hydrochloride treatment in patients with advanced stage breast cancerL M Demers, A Lipton, H A Harvey, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1990
The pharmacodynamic inhibition of estrogen synthesis by fadrozole, an aromatase inhibitor, and its pharmacokinetic dispositionG M Kochak, S Mangat, M T Mulagha, et al.
Cancer|June 15, 1996
Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trialsA U Buzdar, R Smith, C Vogel, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1991
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitorR J Santen, L M Demers, J Lynch, et al.
Pageof 2